ADHD Exercise Rx: Dose-Verified 12-Week Moderate-Intensity Program with Executive-Function Readout
A 12-week exercise plan for kids with ADHD that uses a heart-rate monitor to track progress.
A clinic-issued 12-week exercise prescription for children with ADHD that encodes the evidence-backed dose — chronic, moderate-intensity sessions verified by a basic kids' heart-rate wearable — with brief inhibitory-control and cognitive-flexibility checks that show before/after executive-function gains to the care team.
Concept
A prescription module the pediatrician or ADHD clinician activates at diagnosis or a medication follow-up for children (~6–17) with ADHD. The prescription encodes the dose the evidence supports: chronic sessions (3+ per week for 12 weeks) at moderate intensity, verified through heart-rate zones from an off-the-shelf kids' wearable (or a simple perceived-exertion check where no wearable is available). A companion app schedules sessions, logs completion, and flags dropped intensity or missed weeks. At weeks 0, 6, and 12 the child completes two brief computerized tasks — one tapping inhibitory control, one cognitive flexibility — so the clinician and family receive a one-page before/after executive-function report alongside attendance and intensity data. It is positioned as an adjunct to standard care (medication, behavioral therapy), not a replacement, giving families a concrete, measurable non-drug action instead of vague "get more exercise" advice.
Why now
Paper [0]'s meta-analysis (15 trials in the quantitative synthesis) quantifies the effect with a usable dose for the first time: overall executive-function gains of SMD 0.611 (95% CI 0.386–0.836), inhibitory control g 0.761, and cognitive flexibility g 0.780 — and the subgroup analysis shows that what drives the effect is chronic sessions at moderate intensity, not the type of exercise. That is a buildable specification, not a general platitude. European ADHD Guidelines [6] call for multimodal management and stronger non-pharmacological options, and with roughly 5% prevalence in children and adolescents [2], pediatric practices need scalable adjuncts they can actually monitor. The missing piece — verifying that the dose was delivered and showing the resulting executive-function change — is exactly what the wearable-verified log plus brief task loop provides.
Written by GLM · 9 Oct 2026
AI assessment
A highly focused, evidence-backed clinical tool that transforms vague exercise advice into a verifiable medical prescription with measurable cognitive outcomes.
- Evidence strength 5/5
- The idea directly operationalizes the specific quantitative findings of a meta-analysis (15 trials) regarding dose, intensity, and specific executive function gains (SMD 0.611).
- Market pull 4/5
- Pediatricians and ADHD clinics have a strong incentive to provide non-pharmacological adjuncts, and the 'prescription' format fits existing clinical workflows.
- Novelty & moat 3/5
- While similar to the 'Clinical Exercise Prescription Tool' in the catalog, this is more novel by adding the closed-loop verification (wearables) and the specific executive-function readout.
- Feasibility 5/5
- The system relies on off-the-shelf wearables and existing computerized cognitive tasks, requiring only a coordination layer to be built.
- Wedge clarity 5/5
- The 12-week 'Exercise Rx' is a sharp, time-bound intervention with a clear start and end point, making it easy to pilot in a clinic.
- Simplicity / focus 5/5
- The product is a single, focused tool (Prescription -> Verification -> Report) without unnecessary platform bloat.
Scored by Gemma 4 · 9 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
The largest US ADHD family-advocacy nonprofit; an evidence-dosed, monitorable exercise program gives its member families a concrete non-drug step with measurable executive-function outcomes rather than generic lifestyle advice.
- Child Mind Instituteorganization
A major pediatric ADHD clinic; offering a structured 12-week moderate-intensity exercise prescription with executive-function readouts extends its non-drug treatment line and differentiates its ADHD program.
- American Academy of Pediatricsorganization
Issues the ADHD guidance used by US pediatricians; a standardized exercise-prescription module fits the well-child/ADHD follow-up workflow and operationalizes the non-pharmacological side of management.
- Brightlinecompany
Pediatric behavioral-health telehealth company; adding an exercise-prescription module with wearable-verified dosing extends its ADHD offering beyond therapy and medication management.
- Fitbit (Google)company
Its kids' Ace wearable already tracks heart rate; verifying moderate-intensity dose compliance in a clinical program is a new, defensible use case for the device.
Research it builds on
- Evidence-based pharmacological treatment options for ADHD in children and adolescentsKonstantin Mechler, Tobias Banaschewski, Sarah Hohmann et al. · 2021 · 296 citationsAll ideas from this paper →
- The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)David Coghill, Tobias Banaschewski, Samuele Cortese et al. · 2021 · 178 citationsAll ideas from this paper →
- The impact of exercise interventions concerning executive functions of children and adolescents with attention-deficit/hyperactive disorder: a systematic review and meta-analysisXiao Liang, Ru Li, Stephen Heung‐Sang Wong et al. · 2021 · 151 citationsAll ideas from this paper →